We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,244
Increased
2,720
Reduced
2,447
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.39%
2 Financials 6.67%
3 Healthcare 6.18%
4 Industrials 4.97%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRWG icon
3001
GrowGeneration
GRWG
$86.5M
$4.29M ﹤0.01%
173,990
+149,244
+603% +$5.27M
NX icon
3002
Quanex
NX
$819M
$4.29M ﹤0.01%
200,440
+110,623
+123% +$2.58M
BKKT icon
3003
Bakkt Inc
BKKT
$321M
$4.29M ﹤0.01%
16,971
+14,659
+634% +$3.68M
XPEL icon
3004
XPEL
XPEL
$1.22B
$4.29M ﹤0.01%
56,507
-17,885
-24% -$1.47M
NCLH icon
3005
CALL
Norwegian Cruise Line
NCLH
$8.51B
$4.28M ﹤0.01%
+160,100
New +$4.07M
KEYS icon
3006
CALL
Keysight
KEYS
$54.5B
$4.27M ﹤0.01%
+26,000
New +$4.36M
NTES icon
3007
CALL
NetEase
NTES
$85.3B
$4.27M ﹤0.01%
50,000
THRN
3008
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$4.26M ﹤0.01%
+492,928
New +$4.02M
OLO
3009
DELISTED
Olo Inc
OLO
$4.26M ﹤0.01%
141,866
+128,347
+949% +$4.58M
ARCT icon
3010
Arcturus Therapeutics
ARCT
$164M
$4.26M ﹤0.01%
+89,075
New +$3.99M
SYRE icon
3011
Spyre Therapeutics
SYRE
$8.54B
$4.25M ﹤0.01%
21,409
-318
-1% -$55.6K
PSPC
3012
DELISTED
Post Holdings Partnering Corporation
PSPC
$4.25M ﹤0.01%
+441,370
New +$4.28M
AUDC icon
3013
AudioCodes
AUDC
$244M
$4.25M ﹤0.01%
130,676
+26,640
+26% +$864K
RSKD icon
3014
Riskified
RSKD
$694M
$4.25M ﹤0.01%
+186,398
New +$5.23M
JYAC
3015
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.25M ﹤0.01%
435,713
SGEN
3016
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$4.25M ﹤0.01%
+25,000
New +$3.89M
NBP
3017
NovaBridge Biosciences American Depositary Shares
NBP
$185M
$4.24M ﹤0.01%
58,529
+32,669
+126% +$2.36M
PRG icon
3018
PROG Holdings
PRG
$1.75B
$4.24M ﹤0.01%
100,869
+14,365
+17% +$645K
FTPAU
3019
DELISTED
FTAC Parnassus Acquisition Corp. Unit
FTPAU
$4.23M ﹤0.01%
425,000
-4
-0% -$40
NVSA
3020
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$4.23M ﹤0.01%
433,623
+81,502
+23% +$789K
DAWN
3021
DELISTED
Day One Biopharmaceuticals
DAWN
$4.22M ﹤0.01%
+177,945
New +$4.26M
JBTM
3022
JBT Marel
JBTM
$7.21B
$4.22M ﹤0.01%
30,012
-14,245
-32% -$2.04M
PRPC.U
3023
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$4.21M ﹤0.01%
423,156
-128,073
-23% -$1.28M
ALTR
3024
DELISTED
Altair Engineering Inc
ALTR
$4.21M ﹤0.01%
61,009
-84,953
-58% -$6.06M
XPEV icon
3025
PUT
XPeng
XPEV
$12.4B
$4.2M ﹤0.01%
118,200
+40,000
+51% +$1.59M

Similar funds

Millennium Management's Q3 2021 Portfolio in Review

As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
  • Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.